CCRN4L (also known as Nocturnin) is expressed in a circadian fashion and studies in mice indicate that CCRN4L activates PPAR-γ, a gene that promotes bone adipogensis as opposed to osteoblast formation and that harbors a known diabetes risk variant in humans [58]. The gene discussed is NOCT; the disease is diabetes mellitus.